JAN 30, 2020 9:00 AM PST

An Automated Cancer Organoid Culture Platform to Accelerate Research and Drug Screening

Speaker

Event Date & Time
DATE:  January 30, 2020
TIME:   9:00am PST, 12:00pm EST
Abstract
Recent advances in in vitro 3D cellular culture technologies, such as organoids, rapidly developed and established novel, more physiologically relevant models for basic biology and clinical applications. Traditionally, high-throughput microfluidics and other similar technologies have relied on two-dimensional (2D) cell models for the study of various human conditions and diseases, yet they are not compatible with 3D culture. I will discuss the development of an automatic and dynamic microfluidic ex vivo organoid culture modeling system to facilitate and accelerate preclinical research and the development of personalized treatment strategies. This integrated platform combines microfluidics, automatic dynamic and temporal stimulations (ie combinatorial drug screenings), combined with in silico data analysis and prediction tools. The platform can be used to advance the capabilities of research on cancer organoids models, screen and mirror real life patient chemotherapy treatments and ultimately facilitate treatment decisions for the development of personalized therapies.
 
Learning Objectives:
  • Understand the difference between traditional and microfluidic based cell culture technologies
  • Learn about applying biomedical engineering techniques to advance current 3D cell culture technologies, specifically cancer organoid culture systems 
  • Discover the potential application and capabilities of automatic, high throughput, and dynamic cell culture platforms  
 
Watch our related webinars here:
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

JAN 30, 2020 9:00 AM PST

An Automated Cancer Organoid Culture Platform to Accelerate Research and Drug Screening



Connect with us